The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis
Open accessAbstract
The number of red blood cells is normally tightly regulated by a classic homeostatic mechanism based on oxygen sensing in the kidney. Decreased oxygen delivery resulting from anemia induces the production of erythropoietin, which increases red cell production and hence oxygen delivery. Investigations of erythropoietin regulation identified the transcription factor hypoxia-inducible factor (HIF). HIF is now recognized as being a key regulator of genes that function in a comprehensive range of processes besides erythropoiesis, including energy metabolism and angiogenesis. HIF itself is regulated through the α-subunit, which is hydroxylated in the presence of oxygen by a family of three prolyl hydroxylase domain proteins (PHDs)/HIF prolyl hydroxylases/egg-laying-defective nine enzymes. Hydroxylation allows capture by the von Hippel–Lindau tumor suppressor gene product, ubiquitination, and destruction by the proteasome. Here we describe an inherited mutation in a mammalian PHD enzyme. We show that this mutation in PHD2 results in a marked decrease in enzyme activity and is associated with familial erythrocytosis, identifying a previously unrecognized cause of this condition. Our findings indicate that PHD2 is critical for normal regulation of HIF in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, several PHD2 missense mutations have been identified that resulted in diminished hydroxylase activity. 157, 158”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [157]
In the citing paper
“Patients, who were heterozygous for these mutations were characterized by increased rbc values in the presence of inappropriately normal serum EPO levels. 157–162”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationTargeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationA conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Research works printed but not linked: 4
- Gordeuk, V. R., Stockton, D. W. & Prchal, J. T. (2005) Haematologica 90, 109–116.15642677
- Cario, H., Schwarz, K., Jorch, N., Kyank, U., Petrides, P. E., Schneider, D. T., Uhle, R., Debatin, K. M. & Kohne, E. (2005) Haematologica 90, 19–24.15642664
- Kato, H., Inoue, T., Asanoma, K., Nishimura, C., Matsuda, T. & Wake, N. (2005) Int. J. Cancer 118, 1144–1153.
- Yu, F., White, S. B., Zhao, Q. & Lee, F. S. (2001) Cancer Res. 61, 4136–4142.11358837
Cited by
Sorted by citations
Items 301–334 of 334
Familial erythrocytosis: molecular links to red blood cell control
Min‐Oo, G., Fortin, A., Tam, M. M., Nantel, A., & Mm, S. (2008)
Subcellular localization of hypoxia-inducible factors and HIF regulatory hydroxylases in rat liver.
Khan, Z. (2006) · D-Scholarship@Pitt (University of Pittsburgh)
Dengke, K., Vozdek, R., Bhatla, N., & Horvitz, H. R. (2012)
Oxygen-Dependent Regulation of Erythropoiesis
Haase, V. H. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_23
The Cellular Oxygen Sensor PHD2 in Cancer Growth
Jokilehto, T. (2011) · UTUPub (University of Turku)
Novel Functions of ErbB4 and NRG-1 in Development and Cancer
Paatero, I. (2013) · UTUPub (University of Turku)
Rilevazione di ossigeno, omeostasi e malattia
Semenza, G. L. (2011)
Molecular Genetics of Pheochromocytoma and Paraganglioma
Robledo, M., Currás-Freixes, M., & Cascón, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-46038-3_2
Beneke, A. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6032
Regulation of Cellular Oxygen Sensing Pathways by VHL
Heir, P. (2015) · TSpace (University of Toronto)
Current and Novel Drugs for Management of Anemia
Saikumar, J. H., & Kovesdy, C. P. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7360-6_5
Hétérérogénéité génétique de la polyglobulie
Dabbachi, M. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Tefferi, A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00100-4
Nasseri, M., Keyfi, F., Rahbarian, R., Rajabian, M., & Abbaszadegan, M. R. (2020) · Reports of Biochemistry and Molecular Biology · doi:10.29252/rbmb.9.2.188
Oxygen Sensing, Homeostasis, and Disease
Bels, D. D., Corazza, F., & Balestra, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1110602
家族性赤血球増加症における低酸素誘導因子(HIF)およびHIF制御分子異常
則夫, 小. (2009) · 臨床血液 · doi:10.11406/rinketsu.50.1589
Pihlajaniemi, T. A. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.14143956.15637056
Prchal, J. T. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.14143956.15779475
Tefferi, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00097-9
Weiss, M. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732587239.793577754
Jordan, A. I., Sokol, L., & Zhang, L. (2024) · Springer eBooks · doi:10.1007/978-3-031-62373-8_24
Taber, C. C., He, W., Gasmi-Seabrook, G. M. C., Hubert, M., Ferens, F. G., Ikura, M., Lee, J. D., & Ohh, M. (2025) · eLife · doi:10.7554/elife.107121.3
Taber, C. C., He, W., Gasmi-Seabrook, G. M. C., Hubert, M., Ferens, F. G., Ikura, M., Lee, J. E., & Ohh, M. (2025) · eLife · doi:10.7554/elife.107121.1
Taber, C. C., He, W., Gasmi-Seabrook, G. M. C., Hubert, M., Ferens, F. G., Ikura, M., Lee, J. E., & Ohh, M. (2025) · eLife · doi:10.7554/elife.107121.2
Liang, Y., Dou, X., Huang, H., Tang, Y., Zhang, B., Qiu, W., Zheng, J., Liu, Y., Li, Y., Ye, J., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118035
Clinical and Laboratory Characteristics of JAK2-Unmutated Erythrocytosis - A Study from North India
Gudapati, P., Viswanathan, G. K., Dass, J., Chauhan, R., Aggarwal, M., Kumar, P., Dhawan, R., Ranjan, R., Goel, H., Tanwar, P., et al. (2026) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-026-02447-y
Novel EGLN1 variants identified in patients with erythrocytosis: a functional studyPreprint
Kristan, A., Fekonja, S., & Debeljak, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.12.731943
Reed, X., Weller, C. A., Sáez-Atiénzar, S., Beilina, A. G., Solaiman, S., Portley, M., Kaileh, M., Roy, R., Ding, J., Moore, A. Z., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0356501 · Cited by 3
The Pathogenesis, Diagnosis, and Treatment of Polycythaemia Vera
Dawson, M. A., & Huntly, B. J. P. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_11
Metadata
- Authors
- Percy, M. J., Zhao, Q., Flores, A., Harrison, C., Lappin, T. R. J., Maxwell, P. H., McMullin, M. F., & Lee, F. S.
- Affiliations
- Queen's University Belfast (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-01-09
- Volume
- 103
- Issue
- 3
- Pages
- 654-659
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1334658
- OpenAlex
- W2059951197
- Cited by
- 330
- References
- 49
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 8 · 2023: 7 · 2022: 5 · 2021: 14 · 2020: 11 · 2019: 9 · 2018: 12 · 2017: 12 · 2016: 20 · 2015: 13 · 2014: 16 · 2013: 22 · 2012: 21
- FWCI
- 19.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Funders
- National Cancer Institute (R01CA090261)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- PHD2, familial erythrocytosis, hypoxia-inducible factor, oxygen homeostasis, erythropoietin regulation, von Hippel-Lindau tumor suppressor, erythropoiesis
- MeSH terms
- Adult, Cell Line, Female, Homeostasis, Humans, Isoenzymes, Male, Middle Aged, Oxygen, Polycythemia, Procollagen-Proline Dioxygenase, Protein Binding, Point Mutation, Protein Structure, Tertiary, Immediate-Early Proteins, Amino Acid Substitution, Hypoxia-Inducible Factor 1, alpha Subunit, Hypoxia-Inducible Factor-Proline Dioxygenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
